Article
14 Sep 2026
SEC And FDA Announce New MOU On Cooperation
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
10 Jul 2026
SEC Expands Exemptive Relief For Tender Offers And Exchange Offers For Non-Convertible Debt Securities
Article
29 May 2026
SEC Proposes Significant Reforms To Registered Offering Framework
Article
29 May 2026
SEC Proposes Significant Amendments To Filer Status And Disclosure Requirements
Article
11 May 2026
SEC Proposes To Permit Public Companies To Report Semiannually
Article
01 May 2026
Looking Ahead To Extended Trading – SEC Approves Nasdaq's "23/5" Trading Proposal
Article
27 Apr 2026
New SEC Exemptive Relief For Tender Offers For Equity Securities
Article
16 Mar 2026
Updates Regarding Section 16 And Foreign Private Issuers
Article
13 Jan 2026
Section 16 Reporting To Apply To Directors And Officers Of Foreign Private Issuers
Article
15 Dec 2025
SEC Agrees To Terminate Remaining Undertakings Under The Global Research Analyst Settlement
Article
03 Oct 2025
Potential SEC Shutdown: Considerations For Public Companies And Impact On Capital Markets Transactions
Article
26 Sep 2025
Seeking To Bolster IPOs, SEC Issues Policy Statement Permitting Mandatory Arbitration Of Federal Securities Law Claims
Article
26 Sep 2025
Navigating The Evolving SEC Regime For Foreign Private Issuers: Key Regulatory Debates, Risks And Strategic Considerations